Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos

511075

Sigma-Aldrich

Platelet Activating Factor-16

≥98% (TLC), lyophilized solid, inflammation mediator, Calbiochem®

Sinônimo(s):

Platelet Activating Factor-16, PAF (C₁₆), 1-O-Palmityl-2-acetyl- sn-glycero-3-phosphocholine, 1-O-Hexadecyl-2-acetyl- sn-glycero-3-phosphocholine, PAF (C₁₆), 1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine, 1-O-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Fórmula empírica (Notação de Hill):
C26H54NO7P
Número CAS:
Peso molecular:
523.68
Código UNSPSC:
12352211
NACRES:
NA.77

product name

Platelet Activating Factor-16, A potent mediator of inflammation that increases vascular permeability. Activates MAP kinases and MAP kinase kinase (MEK) in CHO cells.

Nível de qualidade

Ensaio

≥98% (TLC)

forma

lyophilized solid

fabricante/nome comercial

Calbiochem®

condição de armazenamento

OK to freeze
desiccated

cor

white to off-white

solubilidade

ethanol: 0.5-1 mg/mL
water: soluble

Condições de expedição

ambient

temperatura de armazenamento

−20°C

InChI

1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1

chave InChI

HVAUUPRFYPCOCA-AREMUKBSSA-N

Descrição geral

Synthetic water-soluble platelet activating factor. A potent mediator of inflammation that increases vascular permeability. Activates MAP kinase and MAP kinase kinase (MEK) in CHO cells.
Synthetic. A potent mediator of inflammation that increases vascular permeability. Activates MAP kinases and MAP kinase kinase (MEK) in CHO cells.

Ações bioquímicas/fisiológicas

Cell permeable: no
Primary Target
MAP kinases and MAP kinase kinase (MEK)
Product does not compete with ATP.
Reversible: no

Advertência

Toxicity: Standard Handling (A)

Reconstituição

Following reconstitution, aliquot and freeze (-20°C or -70°C) under an inert gas. Aqueous stock solutions are stable for up to 3 days at -20°C. Ethanol stock solutions are stable for up to 3 months at -70°C.

Outras notas

Honda, Z., et al. 1994. J. Biol. Chem. 269, 2307.
Mori, M., et al. 1994. Ann. N.Y. Acad. Sci.744, 107.
Pinckard, R.N., et al. 1992. J. Immunol.148, 3528.
Salari, H., et al. 1992. Biochem. Cell Biol.70, 129.

Informações legais

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 3

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable


Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

R H Adamson et al.
American journal of physiology. Heart and circulatory physiology, 285(1), H406-H417 (2003-03-22)
We tested the hypothesis that acutely induced hyperpermeability is dependent on actin-myosin contractility by using individually perfused mesentery venules of pentobarbital-anesthetized rats. Venule hydraulic conductivity (Lp) was measured to monitor hyperpermeability response to the platelet-activating factor (PAF) 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine or bradykinin.
Emily A Henderson et al.
Frontiers in immunology, 15, 1363962-1363962 (2024-03-22)
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer associated with an immunosuppressive environment. Neutrophil extracellular traps (NETs) were initially described in the context of infection but have more recently been implicated in contributing to the tolerogenic immune response in PDAC.

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica